Stock Price Quote

BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHARMBSE : 532989ISIN CODE : INE878I01014Industry : Pharmaceuticals & DrugsHouse : Private
BSE4.650 (0 %)
PREV CLOSE ( ) 4.65
OPEN PRICE ( ) 4.65
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 100
TODAY'S LOW / HIGH ( )4.65 4.65
52 WK LOW / HIGH ( )4.65 11.88
NSE3.550 (0 %)
PREV CLOSE( ) 3.55
OPEN PRICE ( ) 3.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 4503
TODAY'S LOW / HIGH( ) 3.55 3.85
52 WK LOW / HIGH ( )3.55 13.2
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1995
Management Info
Bafna Mahaveer Chand - Chairman Bafna Mahaveer Chand - Managing Director
Registered Office

Address Bafna Towers,New No 68, Old No.299,Thambu Chetty Street,
Chennai,
Tamil Nadu-600001

Phone 044- 25267517/25270992

Email cs@bafnapharma.com

Website www.bafnapharma.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE, NSE, MCX

NEWS

14Feb Annoucement Under Regulation 30 Of LODR
We would like to inform you that the Board at its meeting held on today..
19Jan Bafna Pharmaceuticals submits sharehol
Bafna Pharmaceuticals has submitted the Shareholding Pattern for the Per..
24Nov Bafna Pharmaceuticals informs about co
Bafna Pharmaceuticals has informed that Radhakrishnan Dharmarajan has be..
21Jul Bafna Pharmaceuticals submits sharehol
Bafna Pharmaceuticals has submitted the Shareholding Pattern for the Per..
28May Bafna Pharmaceuticals’ unit gets renew
Bafna Pharmaceuticals’ facility has received renewal approval as per the..

Financials

in Millions
QTR Dec 19 ANNUAL 19
Net Profit-223.28-197.3
Gross Profit -223.63 -182.3
Operating Profit 2.53999999999999-126.82
Net Sales 109.25433.59

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  15960.00 (1.41%)
M.Cap ( in Cr)33701.39
Sanofi India (BSE)
peergroup  7297.35 (1.69%)
M.Cap ( in Cr)16881.91
Ajanta Pharma (BSE)
peergroup  1394.40 (6.10%)
M.Cap ( in Cr)12309.51
Alkem Laboratories (BSE)
peergroup  2671.00 (1.90%)
M.Cap ( in Cr)31971.68
Piramal Enterprises (BSE)
peergroup  1621.40 (3.14%)
M.Cap ( in Cr)36582.31

Shareholding Pattern

NON-INSTITUTION 73.64%
PROMOTERS 26.36%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 4.65. Its current market capitalisation stands at Rs 11 Cr. In the latest quarter, company has reported Gross Sales of Rs. 0 Cr and Total Income of Rs.0 Cr. The company's management includes K Sabitha, Sunil Bafna, Babulal Kamlesh Kumar, V Rajamani, Paras Bafna, Bafna Mahaveer Chand, Bafna Mahaveer Chand.

It is listed on the BSE with a BSE Code of 532989 , NSE with an NSE Symbol of BAFNAPHARM and ISIN of INE878I01014. It's Registered office is at Bafna Towers,New No 68, Old No.299,Thambu Chetty StreetChennai-600001, Tamil Nadu. Their Registrars are ACC Ltd. It's auditors are Abhay Jain & Co, R Sathyanarayanan & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X